Fletcher Building Ltd:企業の戦略・SWOT・財務情報

◆英語タイトル:Fletcher Building Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C9109
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ニュージーランド
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Fletcher Building Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Fletcher Building Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Fletcher Building Limited (Fletcher Building) is a manufacturer and distributor of building materials. It provides building products, construction materials and related services. The company business operations include construction and manufacturing of cement; steel and building products; decorative surfaces and high pressure laminates and steel roof tiles. It also manufactures and distributes plastic pipeline systems, plumbing, electrical supplies and non-ferrous products. The company carries out the infrastructure projects related providing road maintenance services. Fletcher Building is also involved in the development and sale of residential and commercial properties in New Zealand. The company has operations in Asia Pacific, North America and Europe. Fletcher Building is headquartered in Auckland, New Zealand.

Scope

- Detailed information on Fletcher Building Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Fletcher Building Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Fletcher Building Ltd including a breakdown and examination of key business segments
- Intelligence on Fletcher Building Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Fletcher Building Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Fletcher Building Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Fletcher Building Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Fletcher Building Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Fletcher Building Ltd: Company Overview 9
Fletcher Building Ltd: Overview and Key Facts 9
Fletcher Building Ltd: Overview 9
Fletcher Building Ltd: Key Facts 9
Fletcher Building Ltd: Key Employees 10
Fletcher Building Ltd: Key Employee Biographies 11
Fletcher Building Ltd: Major Products and Services 13
Fletcher Building Ltd: Company History 14
Fletcher Building Ltd: Management Statement 18
Fletcher Building Ltd: Locations and Subsidiaries 22
Fletcher Building Ltd: Key Competitors 24
Fletcher Building Ltd: Company Analysis 25
Fletcher Building Ltd: Business Description 25
Fletcher Building Ltd: SWOT Analysis 27
Fletcher Building Ltd: SWOT Overview 27
Fletcher Building Ltd: Strengths 27
Fletcher Building Ltd: Weaknesses 28
Fletcher Building Ltd: Opportunities 28
Fletcher Building Ltd: Threats 29
Fletcher Building Ltd: Corporate Financial Deals Activity 31
Fletcher Building Ltd: Financial Deals Overview 31
Fletcher Building Ltd: Targets and Partners 33
Fletcher Building Ltd: Top Deals 2014 – 2018YTD* 34
Fletcher Building Ltd: Advisors 35
Fletcher Building Ltd: Top Financial Advisors 35
Fletcher Building Ltd: Mergers and Acquisitions 36
Fletcher Building Ltd: Capital Raising 37
Fletcher Building Ltd: Partnership 38
Fletcher Building Ltd: Divestments 39
Fletcher Building Ltd: Private Equity and Ownership 40
Fletcher Building Ltd: Recent Developments 41
Fletcher Building Ltd: News and Events Summary 41
Fletcher Building Ltd: Business Expansion 43
Fletcher Building Ltd: Contracts 44
Fletcher Building Ltd: Corporate Governance 44
Fletcher Building Ltd: Financial Deals 46
Fletcher Building Ltd: Strategy and Operations 46
Appendix 48
Contact Us 48
Methodology 48
About MarketLine 49

List of Tables
Table 1: Fletcher Building Ltd: Key Facts
Table 2: Fletcher Building Ltd: Key Employees
Table 3: Fletcher Building Ltd: Company History
Table 4: Fletcher Building Ltd: Locations and Subsidiaries
Table 5: Fletcher Building Ltd: Key Competitors
Table 6: Fletcher Building Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Fletcher Building Ltd: M&A Activity by Geography (TTM*)
Table 8: Fletcher Building Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Fletcher Building Ltd: M&A Average Deal Size - Value (US$m)
Table 10: Fletcher Building Ltd: Targets and Partners
Table 11: Fletcher Building Ltd: Top Deals 2014 - 2018YTD*
Table 12: Fletcher Building Ltd: Financial Advisor Ranking by Value (US$m)
Table 13: Fletcher Building Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Fletcher Building Ltd: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Fletcher Building Ltd: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 16: Fletcher Building Ltd: Capital Raising by Deal Type (2014 - YTD*2018)
Table 17: Fletcher Building Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 18: Fletcher Building Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 19: Fletcher Building Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 20: Fletcher Building Ltd: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 21: Fletcher Building Ltd: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 22: Fletcher Building Ltd: News and Events Summary
Table 23: Fletcher Building Ltd: Business Expansion
Table 24: Fletcher Building Ltd: Contracts
Table 25: Fletcher Building Ltd: Corporate Governance
Table 26: Fletcher Building Ltd: Financial Deals
Table 27: Fletcher Building Ltd: Strategy and Operations

List of Figures
Figure 1: Fletcher Building Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Fletcher Building Ltd: M&A Activity by Geography (TTM*)
Figure 3: Fletcher Building Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Fletcher Building Ltd: M&A Average Deal Size - Value (US$m)
Figure 5: Fletcher Building Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Fletcher Building Ltd: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Fletcher Building Ltd: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: Fletcher Building Ltd: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 9: Fletcher Building Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Fletcher Building Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Fletcher Building Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 12: Fletcher Building Ltd: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 13: Fletcher Building Ltd: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Fletcher Building Ltd:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Freehold Royalties Ltd (FRU):企業の財務・戦略的SWOT分析
    Summary Freehold Royalties Ltd (Freehold Royalties), formerly Freehold Royalty Trust is an oil and gas company that offers oil and gas operation and financial performance. Its oil and gas assets generate income from natural gas, crude oil, natural gas liquids and potash deposits. It provides horizon …
  • Lincoln Pharmaceuticals Ltd (LINCOLN):企業の財務・戦略的SWOT分析
    Lincoln Pharmaceuticals Ltd (LINCOLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Porcelanosa Grupo AIE:企業の戦略・SWOT・財務情報
    Porcelanosa Grupo AIE - Strategy, SWOT and Corporate Finance Report Summary Porcelanosa Grupo AIE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hudbay Minerals Inc
    Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Gunsynd Plc (GUN):企業の財務・戦略的SWOT分析
    Gunsynd Plc (GUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Antero Resources Corp (AR):企業の財務・戦略的SWOT分析
    Antero Resources Corp (AR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • The GPT Group (GPT):企業の財務・戦略的SWOT分析
    The GPT Group (GPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • SuanFarma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary SuanFarma SA (SuanFarma Group) is a drug development company that offers production, development, and marketing of raw materials and finished dosage forms. The company’s products portfolio includes amoxiciline capsules, enalapril tablets, colistin methanesulphonate, azitromicine film coated …
  • Atlas Elektronik GmbH:企業の戦略・SWOT・財務情報
    Atlas Elektronik GmbH - Strategy, SWOT and Corporate Finance Report Summary Atlas Elektronik GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Werner Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kumagai Gumi Co Ltd (1861):企業の財務・戦略的SWOT分析
    Kumagai Gumi Co Ltd (1861) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Monsanto Co (MON):製薬・医療:M&Aディール及び事業提携情報
    Summary Monsanto Company (Monsanto) is an agricultural products manufacturing company. It develops and delivers agricultural products to support farmers all around the world. The company develops biotechnology traits that assist farmers in controlling insects and weeds. It also provides other seed c …
  • Cesca Therapeutics Inc (KOOL)-医療機器分野:企業M&A・提携分析
    Summary Cesca Therapeutics Inc (Cesca) researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its device di …
  • Marmen Inc:企業の戦略的SWOT分析
    Marmen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • National Grid Plc (NG):企業の財務・戦略的SWOT分析
    National Grid Plc (NG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • National Fuel Gas Co (NFG):企業の財務・戦略的SWOT分析
    National Fuel Gas Co (NFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Novasep Holding SAS-製薬・医療分野:企業M&A・提携分析
    Summary Novasep Holding SAS (Novasep), formerly Groupe Novasep SAS is a pharmaceutical company which offers services in molecule production and purification for life science and chemical industries. The company offers contract manufacturing and development, custom manufacturing, process engineering, …
  • Euronet Worldwide, Inc.:企業の戦略・SWOT・財務情報
    Euronet Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary Euronet Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Nutra Pharma Corp (NPHC):製薬・医療:M&Aディール及び事業提携情報
    Summary Nutra Pharma Corp (Nutra Pharma) acquires, licenses and commercializes pharmaceutical products, technologies, homeopathic drugs and ethical drugs for managing cancer, neurological disorders, autoimmune and infectious diseases, including human Immunodeficiency virus (HIV), multiple sclerosis …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆